Durability of the two-lumen catheter in hemodialysis patients, which combination has a better effect, ethanol 70%-heparin or cefazolin-heparin: a randomized, double-blind clinical trial study

H. Yousefi, M. Hosseinifard, Mojgan Falaki, Fariba Asadi Noghabi, H. Samimagham, Mohsen yousefi, H. Mardanparvar, J. Vahdatnejad
{"title":"Durability of the two-lumen catheter in hemodialysis patients, which combination has a better effect, ethanol 70%-heparin or cefazolin-heparin: a randomized, double-blind clinical trial study","authors":"H. Yousefi, M. Hosseinifard, Mojgan Falaki, Fariba Asadi Noghabi, H. Samimagham, Mohsen yousefi, H. Mardanparvar, J. Vahdatnejad","doi":"10.34172/npj.2022.10526","DOIUrl":null,"url":null,"abstract":"Introduction: Maintenance of hemodialysis catheters is essential for the patients and medical staff due to their repeated use for hemodialysis and other therapeutic interventions in the hospital. Objectives: This study aimed to comprise the effect of ethanol 70%-heparin versus cefazolin-heparin on the catheter durability time of hemodialysis patients. Patients and Methods: The study population consisted of 73 hemodialysis patients referred to Shahid Mohammadi hospital in Bandar Abbas. Patients were divided into two groups cefazolin (cefazolin 5 mg/dL, and heparin 2500 IU/mL) and ethanol (ethanol 70%, and heparin 2500 IU/mL). In both groups, after each hemodialysis session, 2.9 to 3.3 ml of the locking solution was locked in the catheter lumen and remained until the next session. This intervention was conducted for all patients continuously for five months. The time of catheter durability was calculated from the time of catheter placement in the central vein until the time that it has been taken out according to the doctor’s diagnosis. Data were collected and analyzed by SPSS version 26. Results: Results showed that demographic characteristics, including age, weight, gender, marital status, catheter type, underlying diseases, and dialysis adequacy between the two groups were similar (P>0.05). In the ethanol group, the mean time of the catheter durability was 27.5 days, and in the cefazolin group was 26.98 days. Although the time of the catheter durability was slightly higher in the ethanol group, this difference was not significant (P=0.194). Conclusion: Cefazolin and ethanol 70% did not show a significant difference in the catheter durability time of hemodialysis patients. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (IRCT20210811052145N1; https://en.irct.ir/trial/58037, ethical code; IR.HUNS.REC.1398.052).","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephropharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/npj.2022.10526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Maintenance of hemodialysis catheters is essential for the patients and medical staff due to their repeated use for hemodialysis and other therapeutic interventions in the hospital. Objectives: This study aimed to comprise the effect of ethanol 70%-heparin versus cefazolin-heparin on the catheter durability time of hemodialysis patients. Patients and Methods: The study population consisted of 73 hemodialysis patients referred to Shahid Mohammadi hospital in Bandar Abbas. Patients were divided into two groups cefazolin (cefazolin 5 mg/dL, and heparin 2500 IU/mL) and ethanol (ethanol 70%, and heparin 2500 IU/mL). In both groups, after each hemodialysis session, 2.9 to 3.3 ml of the locking solution was locked in the catheter lumen and remained until the next session. This intervention was conducted for all patients continuously for five months. The time of catheter durability was calculated from the time of catheter placement in the central vein until the time that it has been taken out according to the doctor’s diagnosis. Data were collected and analyzed by SPSS version 26. Results: Results showed that demographic characteristics, including age, weight, gender, marital status, catheter type, underlying diseases, and dialysis adequacy between the two groups were similar (P>0.05). In the ethanol group, the mean time of the catheter durability was 27.5 days, and in the cefazolin group was 26.98 days. Although the time of the catheter durability was slightly higher in the ethanol group, this difference was not significant (P=0.194). Conclusion: Cefazolin and ethanol 70% did not show a significant difference in the catheter durability time of hemodialysis patients. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (IRCT20210811052145N1; https://en.irct.ir/trial/58037, ethical code; IR.HUNS.REC.1398.052).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
双腔导管在血液透析患者中的耐久性:一项随机、双盲临床试验研究,乙醇70%肝素或头孢唑林肝素联合使用效果更好
简介:由于血液透析导管在医院反复用于血液透析和其他治疗干预措施,因此维护血液透析导管对患者和医务人员来说至关重要。目的:本研究旨在包括70%乙醇肝素与头孢唑林肝素对血液透析患者导管耐久时间的影响。患者和方法:研究人群包括73名血液透析患者,他们被送往阿巴斯港的Shahid Mohammadi医院。患者分为两组:头孢唑林(头孢唑林5 mg/dL,肝素2500 IU/mL)和乙醇(乙醇70%,肝素2500 IU/mL)。在两组中,在每次血液透析疗程后,将2.9至3.3毫升的锁定溶液锁定在导管内腔中,并保持到下一疗程。该干预措施对所有患者连续进行了五个月。导管耐久性的时间是从导管放置在中心静脉的时间开始计算的,直到根据医生的诊断取出为止。数据采用SPSS 26版软件进行统计分析。结果:结果显示,两组之间的人口统计学特征,包括年龄、体重、性别、婚姻状况、导管类型、潜在疾病和透析充分性,相似(P>0.05)。乙醇组导管耐久性的平均时间为27.5天,头孢唑林组为26.98天。尽管乙醇组的导管耐久性时间略高,但这一差异并不显著(P=0.194)。结论:头孢唑林和70%乙醇在血液透析患者的导管耐久时间方面没有显著差异。试验注册:试验方案由伊朗临床试验注册处批准(IRCT2021081052145N1;https://en.irct.ir/trial/58037,道德规范;IR.HUNS.REC.1398.052)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Nephropharmacology
Journal of Nephropharmacology Medicine-Pharmacology (medical)
CiteScore
1.70
自引率
0.00%
发文量
18
审稿时长
4 weeks
期刊最新文献
Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial Renal insufficiency in breast cancer patients; a review study The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology Oncocardiology: close collaboration between oncologists, cardiologists, and nephrologists
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1